Related Experiment Video
Updated: Jun 2, 2026

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
Continuous saline bladder irrigation after transurethral resection is a prophylactic treatment choice for non-muscle
Takehisa Onishi1, Takeshi Sasaki, Akira Hoshina
1Department of Urology, Yamada Red Cross Hospital, Ise, Mie, Japan.takehisa@yamada.jrc.or.jp
Background:
Instillation of chemotherapy after transurethral resection (TUR) has been considered as an optimal treatment for non-muscle invasive bladder cancer (NMIBC). However, controversy remains regarding the role of chemotherapy instillation. We therefore evaluated the usefulness of continuous saline bladder irrigation (CSBI) after TUR.
Patients And Methods:
Patients with intermediate risk NMIBC were treated by TUR followed by either CSBI (123 patients) or intravesical instillation of mitomycin C (115 patients). Recurrence-free rates were estimated using the Kaplan-Meier method.
Results:
No significant differences were observed in the recurrence-free rate, period to first recurrence, nor in frequency of recurrence between the CSBI and intravesical chemotherapy groups. Tumor progression rate and local toxicities were significantly higher in the intravesical chemotherapy group.
Conclusion:
CSBI after TUR appears to be a prophylactic treatment choice for intermediate risk NMIBC patients, in terms of its equal prophylactic effect to intravesical chemotherapy with mitomycin C, and its safety and cost benefits.
Related Concept Videos
Urologic Endoscopic Procedure: Cystoscopic Examination
Urinary Tract Calculi VI: Surgical Management
Kidney Transplant II: Surgical Procedure
Imaging Studies II: Ultrasonography
Imaging Studies VI: Voiding Cystourethrography and Cystography
Urinary Tract Infection IV: Nursing Management
